Page last updated: 2024-09-05

tolvaptan and aliskiren

tolvaptan has been researched along with aliskiren in 4 studies

Compound Research Comparison

Studies
(tolvaptan)
Trials
(tolvaptan)
Recent Studies (post-2010)
(tolvaptan)
Studies
(aliskiren)
Trials
(aliskiren)
Recent Studies (post-2010) (aliskiren)
967172786978211611

Protein Interaction Comparison

ProteinTaxonomytolvaptan (IC50)aliskiren (IC50)
ReninHomo sapiens (human)0.001
Renin-1 Mus musculus (house mouse)0.0045
Renin Rattus norvegicus (Norway rat)0.084
Cytochrome P450 3A4Homo sapiens (human)0.0004
Cytochrome P450 2C9 Homo sapiens (human)0.0023
ReninMacaca mulatta (Rhesus monkey)0.0012
Renin Oryctolagus cuniculus (rabbit)0.011

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Harman, C1
Horowitz, J; Kaski, JC; McMurray, JJ; Recio-Mayoral, A; Remme, WJ; van Veldhuisen, DJ1
Chivite, D; Corbella, X; Formiga, F1

Reviews

2 review(s) available for tolvaptan and aliskiren

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
    Medicina clinica, 2014, Volume: 142 Suppl 1

    Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan

2014

Other Studies

2 other study(ies) available for tolvaptan and aliskiren

ArticleYear
What new drugs can nephrologists look forward to in the next year or two?
    Nature clinical practice. Nephrology, 2007, Volume: 3, Issue:5

    Topics: Amides; Anemia; Antihypertensive Agents; Benzazepines; Drug Administration Schedule; Drug Approval; Drug Combinations; Drug Delivery Systems; Erythropoietin; Ferrosoferric Oxide; Fumarates; Humans; Hyponatremia; Immunosuppressive Agents; Kidney Diseases; Nanoparticles; Nephrology; Renal Dialysis; Renin; Tacrolimus; Tolvaptan

2007
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
    Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6

    Topics: Abciximab; Acute Coronary Syndrome; Amides; Antibodies, Monoclonal; Benzazepines; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Europe; Fumarates; Heart Diseases; Heart Failure; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptide Fragments; Probucol; Recombinant Proteins; Ticlopidine; Tolvaptan

2007